Results 181 to 190 of about 21,572 (212)

Drug-Induced Lung Injury With Drug Eruption Due to Apalutamide Followed by Switch to Bicalutamide: A Case Report. [PDF]

Cureus
Tanaka N, Kitahara K, Kusunoki Y, Sunaga T.   +3 more
europepmc   +1 more source

Fixed drug eruption induced by Etoricoxib in Thailand: A case report. [PDF]

Toxicol Rep
Siriwattanasatorn M, Kamudhamas A, Sivapornpan N, Noonpugdee M, Kamalashiran C, Phetkate P.   +5 more
europepmc   +1 more source

Eccrine Squamous Syringometaplasia Mimicking Acute Cutaneous GVHD in a Pediatric HSCT Recipient: Case Report and Brief Review of the Indexed Literature

Journal of Cutaneous Pathology, Volume 53, Issue 9, Page 792-802, September 2026.
ABSTRACT Eccrine squamous syringometaplasia (ESS) is an uncommon reactive alteration of eccrine ducts, most often reported in oncologic and transplant settings, where it may clinically mimic acute cutaneous graft‐versus‐host disease (GVHD). We describe a 3‐year‐old boy with chronic granulomatous disease who developed a diffuse erythematous eruption 6 ...
Benedetta Galli, Cecilia Catapano, Iacopo Ghini, Mariateresa Rossi, Marina Venturini, Valeria Boccaletti   +5 more
wiley   +1 more source

Inducing Antigen‐Specific and Functional Immune Responses in Mice Toward Bovine Herpesvirus 1 and Bovine Respiratory Syncytial Virus by Chimeric Peptides Delivered by Bovine Herpesvirus 4‐Based Vector

Immunology, Volume 179, Issue 1, Page 54-71, September 2026.
Bovine Alphaherpesvirus 1 (BoHV‐1) and Bovine respiratory syncytial virus (BRSV) are major drivers of respiratory disease in cattle. (A) To target both pathogens, two chimeric antigens—membrane‐linked and secreted—combining BoHV‐1 glycoprotein D and BRSV fusion glycoprotein were designed and expressed using recombinant BoHV‐4‐based vectors.
Antonino Di Lorenzo, Sergio Minesso, Chiara Cossu, Valentina Franceschi, Elisabetta Bolli, Vittorio Madia, Laura Conti, Gaetano Donofrio   +7 more
wiley   +1 more source

Fixed drug eruption in a cribriform pattern: an atypical presentation. [PDF]

Skin Health Dis
Mathur M, Thakur N, Regmi S, Paudel S, Bhattarai N, Karki S.   +5 more
europepmc   +1 more source

A case of recurrent fixed drug eruption triggered by a hormonal intrauterine device. [PDF]

JAAD Case Rep
Awad N, Fontaine D, Schiele K, Regmi A, Sriharan A, Fragoso NM.   +5 more
europepmc   +1 more source

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

British Journal of Clinical Pharmacology, Volume 92, Issue 8, Page 2937-2948, August 2026.
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber, Sophie‐Charlotte Bartel, Michael Boch, Christoph Rosen, Michael Bodmer, Balthasar Luzius Hug, Thomas Stammschulte, Patrick E. Beeler   +7 more
wiley   +1 more source

A critical appraisal and questions on the immunological evolution of mogamulizumab-induced drug eruption into cutaneous adult T-cell leukemia/lymphoma infiltration. [PDF]

JAAD Case Rep
Aphale P, Shekhar H, Dokania S.
europepmc   +1 more source

Fluoroquinolone-induced generalised fixed drug eruption: a rare clinical image. [PDF]

Pan Afr Med J
Bollineni S, Aurangabadkar G.
europepmc   +1 more source